Glassman Wealth Services Alkermes Plc. Transaction History

Glassman Wealth Services

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$23.07 - $27.99 $738 - $895	-32 Reduced 15.46%	175 $5,000
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $2,490 - $3,721	-116 Reduced 35.91%	207 $5,000
Q3 2021 Nov 10, 2021	SELL	$23.37 - $32.13 $2,383 - $3,277	-102 Reduced 24.0%	323 $10,000
Q1 2021 May 05, 2021	BUY	$18.21 - $23.2 $783 - $997	43 Added 11.26%	425 $8,000
Q4 2020 Feb 04, 2021	BUY	$15.39 - $22.1 $3,601 - $5,171	234 Added 158.11%	382 $8,000
Q3 2020 Nov 09, 2020	BUY	$16.16 - $20.66 $177 - $227	11 Added 8.03%	148 $2,000
Q2 2020 Aug 06, 2020	BUY	$13.31 - $19.41 $1,131 - $1,649	85 Added 163.46%	137 $3,000
Q1 2020 May 12, 2020	BUY	$13.06 - $21.24 $679 - $1,104	52 New	52 $1,000
Q4 2019 Feb 07, 2020	SELL	$17.29 - $21.74 $795 - $1,000	-46 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$19.51 - $24.28 $643 - $801	33 Added 253.85%	46 $1,000
Q2 2019 Aug 08, 2019	BUY	$21.47 - $37.33 $279 - $485	13 New	13 $0

363

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.72B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.